Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Petar Bajic, MD

Advertisement

Articles by Petar Bajic, MD

Source: Reprinted from Urology 2019; 126:11 with permission from Elsevier

Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome

ByRyan A. Dornbier, MD,Petar Bajic, MD,Gopal N. Gupta, MD
August 26th 2019

Study findings have implications for noninvasive markers to predict the course of UCC

Advertisement

Latest Updated Articles

  • Source: Reprinted from Urology 2019; 126:11 with permission from Elsevier
    Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome

    August 26th 2019



Advertisement
Advertisement

Trending on Urology Times

1

Belzutifan plus lenvatinib maintains PFS benefit vs cabozantinib in advanced ccRCC

2

Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC

3

Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026

4

Chad Ritch, MD, on using PSMA-PET to guide treatment decisions

5

How Phase 3 Trials Are Reshaping Perioperative MIBC Regimen Selection

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us